Rusch VW - Search Results

1

Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma.

Kachala SS, Bograd AJ, Villena-Vargas J, Suzuki K, Servais EL, Kadota K, Chou J, Sima CS, Vertes E, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Kachala SS, et al. Among authors: rusch vw. Clin Cancer Res. 2014 Feb 15;20(4):1020-8. doi: 10.1158/1078-0432.CCR-13-1862. Epub 2013 Dec 13. Clin Cancer Res. 2014. PMID: 24334761 Free PMC article.

2

Survival after resection of stage II non-small cell lung cancer.

Martini N, Burt ME, Bains MS, McCormack PM, Rusch VW, Ginsberg RJ. Martini N, et al. Among authors: rusch vw. Ann Thorac Surg. 1992 Sep;54(3):460-5; discussion 466. doi: 10.1016/0003-4975(92)90435-7. Ann Thorac Surg. 1992. PMID: 1324654 Free article.

3

Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer.

Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, Kris M, Dmitrovsky E. Rusch V, et al. Cancer Res. 1995 Nov 1;55(21):5038-42. Cancer Res. 1995. PMID: 7585548

4

Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.

Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J, Dmitrovsky E. Rusch V, et al. Cancer Res. 1993 May 15;53(10 Suppl):2379-85. Cancer Res. 1993. PMID: 7683573

5

Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.

Rusch V, Klimstra D, Linkov I, Dmitrovsky E. Rusch V, et al. Cancer Res. 1995 Mar 15;55(6):1365-72. Cancer Res. 1995. PMID: 7882337

6

Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.

Rusch V, Klimstra D, Venkatraman E, Pisters PW, Langenfeld J, Dmitrovsky E. Rusch V, et al. Clin Cancer Res. 1997 Apr;3(4):515-22. Clin Cancer Res. 1997. PMID: 9815714

7

Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer.

Martini N, Rusch VW, Bains MS, Kris MG, Downey RJ, Flehinger BJ, Ginsberg RJ. Martini N, et al. Among authors: rusch vw. J Thorac Cardiovasc Surg. 1999 Jan;117(1):32-6; discussion 37-8. doi: 10.1016/s0022-5223(99)70467-8. J Thorac Cardiovasc Surg. 1999. PMID: 9869756 Free article.

8

Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.

Lonardo F, Rusch V, Langenfeld J, Dmitrovsky E, Klimstra DS. Lonardo F, et al. Cancer Res. 1999 May 15;59(10):2470-6. Cancer Res. 1999. PMID: 10344760

9

The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia.

Parekh K, Rusch V, Kris M. Parekh K, et al. Cancer. 1999 Nov 1;86(9):1720-3. Cancer. 1999. PMID: 10547544

10

Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.

Boyle JO, Lonardo F, Chang JH, Klimstra D, Rusch V, Dmitrovsky E. Boyle JO, et al. Clin Cancer Res. 2001 Feb;7(2):259-66. Clin Cancer Res. 2001. PMID: 11234877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

489 results

Search Page

Filters